Skip to main content
OpenTrials
Completed

NCT Number: NCT00356044

Arterial Access for Coronary Intervention in Myocardial Infarction

The aim of this study is to compare the radial and femoral access for percutaneous interventions in the acute phase of the ST elevation acute myocardial infarction in terms of efficacy and security.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Hospital Juan Canalejo, A Coruña, Spain

Loading trial locations.

About this study

Some groups have previously used the radial artery as the access route in the procedures of percutaneous coronary revascularization, with good results. The advantages of the radial compared with femoral access are related to a lower incidence of vascular complications. The radial access has also inconveniences such as a less predictable anatomy which can make the procedure difficult and prolong the time required.The patients with ST elevation myocardial infarction have an increased risk of vascular complications after interventional procedures because previous antithrombotic or thrombolytic therapy.On the other hand, the time and success of the procedure are significant prognostic issues.In this sitting, the radial approach might reduce vascular complications and increase other cardiovascular events when comparing with the classical femoral access. For this reason, the purpose of the study is to compare both arterial access in terms of efficacy and security and to quantify the consequences of the advantages and drawbacks of both.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with ST elevation acute myocardial infarction referred for primary,facilitated or of rescue coronary angioplasty in the first 12 hours since the start of the symptoms.

Exclusion criteria

  • Patients in cardiogenic shock were excluded following operator criteria.
  • Previous coronary surgery with mammary artery graft
  • Coronary artery intervention in the previous month
  • Absolute or relative contraindication for access via the radial artery route:Radial pulse absent or weak, abnormal Allen test,anatomy known to impede the use of the radial route or hemodialysis or advanced chronic renal insufficiency (creatinine >3 mg/dl).
  • Patients with absolute or relative contraindication for the use of the femoral route.
  • Absence of informed consent from the patient

Treatment and study plan

Coronary angioplasty

Procedure

Primary outcomes

  1. All cause mortality at 30 days

    Time frame: within the first 30 days (plus or minus 5 days) after the index myocardial infarction

  2. New ST elevation acute myocardial infarction at 30 days

    Time frame: within the first 30 days (plus or minus 5 days) after the index myocardial infarction

  3. Coronary revascularization as a result of recurrent ischemia at 30 days

    Time frame: within the first 30 days (plus or minus 5 days) after the index myocardial infarction

  4. Major vascular complications at 30 days.

    Time frame: within the first 30 days (plus or minus 5 days) after the index myocardial infarction

Secondary outcomes

  1. Embolic stroke at 30 days

    Time frame: within the first 30 days (plus or minus 5 days) after the index myocardial infarction

  2. Coronary revascularization at 30 days

    Time frame: within the first 30 days (plus or minus 5 days) after the index myocardial infarction

  3. Cardiovascular mortality at 30 days

    Time frame: within the first 30 days (plus or minus 5 days) after the index myocardial infarction

  4. Procedural time

  5. Hospital stay

  6. Estimation of costs

Sponsors and collaborators

Lead sponsor

Hospital Juan Canalejo

Other

Registry information

Official study title

Femoral Versus Radial Access for Coronary Intervention in the Acute Phase of ST-Elevation Myocardial Infarction

Important dates

Study start
2004
Study completion
2005
First posted
Jul 25, 2006
Registry last updated
Jul 11, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.